Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?



Investing as Shakespearean Tragedy: The Story of Ariad Pharmaceutical (ARIA)

By  +Follow November 12, 2013 8:57AM
Tickers Mentioned:

Shares in Ariad Pharmaceuticals (ARIA) were up 10.78 percent on Veterans Day. Even for a small-cap like Ariad, coming in at a valuation just under a half billion dollars, that’s normally what one would consider a pretty solid bounce. That’s a day that, for a lot of investors, would stand out. However, for the battered shareholders of Ariad, it probably doesn’t even register any more. Okay, that’s not true, double-digit jumps always register. But after the Odyssey Ariad’s been on for the last month, it’s not difficult to imagine that days like Monday just get lost in the shuffle.

It’s not often you see a company go on a ride like Ariad just has, plunging sharply, appearing to rally, rinse and repeat. And it’s a drama that’s swept a lot of people up. Over the last 3 months, Ariad’s moved an average of 11.14 million shares a day, good to make it the 75th most traded security over that period, one spot behind Elon Musk’s Tesla Motors (TSLA) , a battleground stock and the source of general market fascination. That’s a class that contains mostly mega-cap blue chips and high-profile ETFS, relatively few small-cap companies. And that’s not even the whole story. Ariad’s heavy volume is drawn mostly from the massive spike this last month. Over the last 30 days Aria has been moving an average of 20 million shares a day, meaning that more than 10 percent of outstanding shares are trading hands on an average day.

So what’s happening with this company? The story’s a simple one, but, for Ariad investors, it’s a tragic one.

Volatile Month

Lets start with the whole story: since the start of October, Ariad Pharmaceutical’s stock has lost over 85 percent of its value. No matter how specifically you pull things apart, that’s the simple fact one cannot avoid. Especially if you’ve owned Ariad for that whole stretch. But inside that one big sell-off is a series of daily price moves that could drive an investor insane. Here’s a timeline or the events that have brought Ariad so much grief:

October 8:

After market close, news gets out regarding the clinical trials for Ariad’s leukemia drug Iclusig and it’s bad. In fact, if you’re long Ariad, it’s positively awful. The drug showed blood clots developing in 11.8 percent of people treated with Iclusig after 24 months. This was a big jump from the 8 percent rate found after 11 months, and it prompts the FDA to block Ariad from enrolling any new patients to drug trials for Iclusig.

Like most small-cap pharma companies, Ariad’s future is tied mainly to just a couple of drugs, and the news that one of them might not be safe is pretty drastic. Especially when one considers that the nearly 800 percent gains from the start of 2010 to October 7 had a lot to do with the fact that Iclusig looked so promising, even getting accelerated approval based on its Phase 2 clinical data.

So it shouldn’t be surprising that the market’s reaction was swift and vengeful. As soon as investors got a crack at selling their position on October 9 shares plummeted over 65 percent.

October 10-18:

If the story ended there, it would be pretty much in line with a familiar narrative: small-cap pharma plummets on negative results of clinical trial. But, while nothing matched the degree of the move on the ninth, Ariad kept trading at heavy volumes and kept posting double-digit moves.

A series of analyst downgrades hit the company on October 10, with Barclays (BCS) downgrading the stock from overweight to underweight and cutting the price target from $25 a share to $4 (ouch). The stock kept falling, losing another 30 percent from October 10-16 but coasting into what appeared to be a bottom on October 16.

Then, on October 17, signs of life! Following comments from JP Morgan (JPM) analyst Cory Kasimov that physicians may not be all that concerned about the blood clots, the stock rebounded, posting a 10.78 percent gain and potentially giving hope to Ariad owners that the worst was behind them.

Except that it wasn’t. Not at all. October 18, word came out that Ariad and the FDA had agreed to halt testing of Iclusig entirely based on the rate of blood clotting incidences. The discontinuation of the late-stage trial dubbed Epic by Ariad caused shares to plunge more than 40 percent that day.

October 21-October 30:

After any stock gets hammered that hard in that short a period, one might expect it to bounce back. At least a little. Considering how steep the discount it’s trading at as compared to a mere two weeks ago, it has to garner at least a little interest, right?

And it did. The company staged a pretty substantial rally, gaining almost 50 percent in just nine days. It’s not much when one considers just how fall the stock fell prior to the rally, but at least the battered shareholders got a respite in the end, right?

October 31:

Only it wasn’t the end. Halloween was extra spooky if you had decided to wait out Ariad’s steep decline. Ariad announced that it would suspend marketing and distribution of Iclusig while it "continues to negotiate updates to the U.S. prescribing information." In retrospect, it certainly seems as though this shouldn’t have been all that surprised, but it clearly surprised at least some people as the company’s stock plunged nearly 45 percent.

And Beyond…?

Where Ariad’s going from here is unclear. Since the start of November, the stock’s up over 15 percent, including a 17.27 percent leap the day after Halloween and Monday’s double-digit gain. However, precisely what to expect moving forward is unclear. In the event that Ariad can return Iclusig to the market and ensure that it’s safe, there’s a pretty good chance the stock takes off. That said, there’s no real way to know whether or not that’s possible. In the meantime, the company announced that it was shedding 40 percent of its American-based workforce on November 7.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for ARIA
30 Jul 15 12:00:02
#sentishiftup $XLV $I $MXL $CVX $VXX $SPXU $EEM $ARIA $HPQ $DAL #sentiquant #FinTech 20150730 15:00:05:027
Michael Cook
30 Jul 15 11:30:05
Our Stock Alerts Gained Over 550% This Month Already! See Our Huge New Pick Coming This Week: http://t.co/abs4Q0eCx9 $FASC $ARIA $TUCN
Michael James
30 Jul 15 11:26:16
After A MASSIVE 525% Gain On $GEQU, We Have A New Pick Ready! Special Update: http://t.co/wFGuoX67mX $FASC $ARIA $TUCN
Paul Henry
30 Jul 15 11:23:49
Our Penny Stock Picks Have Gained 3,600% In 10 Months! Get Early Access To Our Next Pick: http://t.co/xXdYdpAiFK $FASC $ARIA $TUCN
30 Jul 15 11:11:01
Covered Call Alert: ARIAD PHARMACEUTICALS $ARIA returning up to 36.80% through 15-Jan-2016 http://t.co/20McwVQE7e
30 Jul 15 11:01:26
RT Sentiquant: #sentishiftup $XLV $CVX $MXL $VXX $I $SPXU $EEM $ARIA $HPQ $RDUS #sentiquant #FinTech 20150730 14:00:05:017
30 Jul 15 11:00:03
#sentishiftup $XLV $CVX $MXL $VXX $I $SPXU $EEM $ARIA $HPQ $RDUS #sentiquant #FinTech 20150730 14:00:05:017
30 Jul 15 10:56:40
$SPNC Spectranetics http://t.co/UKZ3MRGmpH $KMI $WMT $CEMP $NAT $AAPL #pennystocks $MYEC $SGYP $ARIA $NVAX #MYEC $FB $NFLX $AMZN $CEMEX
30 Jul 15 10:40:18
$ARIA Company Update (NASDAQ:ARIA): Ariad Pharmaceuticals, Inc. to Receive up to ... http://t.co/LM1nB6OMwv
Clair Voight
30 Jul 15 10:40:05
$ARIA Active Stocks Traders Alert: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), E I Du ... http://t.co/FLz2moDW4M
Daily Contracts
30 Jul 15 10:27:52
$ARIA News: News Release http://t.co/3s8GxAv5Wy #newsrelease #ariadpharmaceuticals
James McGough
30 Jul 15 09:49:08
RT @biospace: Four #Boston #Biotechs That Could Make M&A Moves This Year: $VRTX $BIIB $SHPG $ARIA http://t.co/aSBdw0W3Jy http://t.co/U0n5tH…
30 Jul 15 09:45:56
$SPNC Spectranetics http://t.co/UKZ3MRGmpH $KMI $WMT $CEMP $NAT #pennystocks $MYEC $SGYP $ARIA $NVAX #MYEC $FB $NFLX $AMZN $JBLU $cctl
Deep Dive
30 Jul 15 09:24:00
$CELG $ARIA $EPZM $ILMN $ALXN Celgene Corp. Earnings Analysis By the Numbers http://t.co/RdfbosAeDs http://t.co/3uuKZHtliY
30 Jul 15 09:22:59
$ARIA $GSAT $ITEK $KN $NKTR $SONS $SRPT $SSRI $VRTX autocharts @ http://t.co/cLiki3R0GR
30 Jul 15 09:00:02
#sentishiftup $CVX $VXX $XLV $MBLY $IBB $BP $PFE $ARIA $RDUS $HPQ #sentiquant #FinTech 20150730 12:00:06:282
Sabina Attwood
30 Jul 15 08:43:57
RT @BioWorld: $ARIA's synthetic royalty deal with $PDLI garners $200M for cancer programs but doesn't thrill investors as shares fall 6%
Michael Cook
30 Jul 15 08:20:09
Our Stock Alerts Gained Over 550% This Month Already! See Our Huge New Pick Coming This Week: http://t.co/abs4Q0wdoH $FASC $ARIA $TUCN
Michael James
30 Jul 15 08:16:16
After A MASSIVE 525% Gain On $GEQU, We Have A New Pick Ready! Special Update: http://t.co/wFGuoX67mX $FASC $ARIA $TUCN
Paul Henry
30 Jul 15 08:12:19
Our Penny Stock Picks Have Gained 3,600% In 10 Months! Get Early Access To Our Next Pick: http://t.co/xXdYdpAiFK $FASC $ARIA $TUCN
Harry Walkman
30 Jul 15 08:10:54
$ARIA Active Stocks Traders Alert: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), E I Du ... http://t.co/ZIDBpZ1yWj
30 Jul 15 07:49:59
$ARIA $GFI $MNKD $OCN $REXX $SSYS $TEX $UPL $VDSI autocharts @ http://t.co/cLiki3R0GR
James DiPlata
30 Jul 15 07:27:04
RT @danrocks4: ARIA db X-Trackers Harvest CSI 300 China A-Shares Fund Prev Close http://t.co/Mu2ulQa4wT $ARIA $BABA $VLO $UNIS #ARIA #nasd…
30 Jul 15 07:25:54
Active Stocks Traders Alert: http://t.co/m054BE9BvM $ARIA $DD $AIZ
30 Jul 15 07:18:06
$ARIA active, relative volume: 5.08, 1H, 10:00 AM, #nasdaq http://t.co/Csk7miIhta http://t.co/Csk7miIhta
Marie Powers
30 Jul 15 07:13:26
RT @BioWorld: $ARIA synthetic royalty deal with $PDLI to back cancer programs http://t.co/v27izLmgdz
30 Jul 15 07:06:29
$ARIA active, relative volume: 5.08, 1H, 10:00 AM, #nasdaq http://t.co/Csk7miIhta
Alpha Maven Alerts
30 Jul 15 07:00:43
$ARIA active, relative volume: 5.08, 1H, 10:00 AM, #nasdaq
30 Jul 15 06:59:55
Four #Boston #Biotechs That Could Make M&A Moves This Year: $VRTX $BIIB $SHPG $ARIA http://t.co/aSBdw0W3Jy http://t.co/U0n5tH6Kk5
30 Jul 15 06:51:35
WPG World Wrestling Entertainment, Inc. Yield http://t.co/pHfrmZwdVB $WPG $AGN $ARIA $FV #WPG #investing #stockmarket
BioWorld Today
30 Jul 15 06:49:00
$ARIA synthetic royalty deal with $PDLI to back cancer programs http://t.co/v27izLmgdz
30 Jul 15 06:48:06
VGTL Valero Energy Corp 52Wk Low http://t.co/0INVQ4Rtiv $VGTL $ARIA $SPXL $ASHR #VGTL #pennystocks #investing
IH News Desk
30 Jul 15 06:48:04
VRTX Valeant Pharmaceuticals Intl, Inc. Exchange http://t.co/i6l12Vr2b8 $VRTX $XLE $UGAZ $ARIA #VRTX #share #invest
30 Jul 15 06:47:40
TQQQ Thomson Reuters Corp. Prev Close http://t.co/czjDNWPNlC $TQQQ $AGN $HIMX $ARIA #TQQQ #share #stockmarket
30 Jul 15 06:47:37
UUP ProShares Ultra VIX Short-Term Futures ETF Stock Message Board http://t.co/AkPVCbcIct $UUP $ARIA $FB $CLVS #UUP #stockmarket…
30 Jul 15 06:47:37
TBT iShares Barclays 20+ Year Treasury Bond Fund Bid Size http://t.co/onqGF4eeCN $TBT $ARIA $FIT $SLW #TBT #pennystocks #share
30 Jul 15 06:46:25
TQQQ Tesla Motors Inc. Stock Forum http://t.co/McZfFoAr7E $TQQQ $TSLA $ARIA $BABA #TQQQ #finance #tradeideas
Lucky Jimmy
30 Jul 15 06:46:16
TLT Direxion Daily Small Cap Bull 3x Shares Market Cap http://t.co/yBRQgXD3Ga $TLT $IJR $ARIA $GLD #TLT #stock #share
IH News Desk
30 Jul 15 06:45:08
SLV Silver Wheaton Corp. Ideas http://t.co/6uk7upkP5e $SLV $EWC $ARIA $MU #SLV #stocks #stockmarket
30 Jul 15 06:44:44
IWM Direxion Daily Junior Gold Miners Index Bear 3X Shares Summary http://t.co/dU7lAvM4Eg $IWM $IMSC $ARIA $QTMM #IWM #invest…
30 Jul 15 06:43:32
GG Gilead Sciences, Inc. Stock Forum http://t.co/gztq3ohrxq $GG $AA $MINE $ARIA #GG #finance #stock
Investors Hangout
30 Jul 15 06:43:14
QTMM Rite Aid Corp. Chart http://t.co/v4LnjsMrnj $QTMM $EEM $ARIA $ROST #QTMM #tradeideas #stocks
IH News Desk
30 Jul 15 06:43:12
QLD Qorvo, Inc. News http://t.co/Uf34OOMqzK $QLD $ARIA $SGYP $SWKS #QLD #finance #stockmarket
30 Jul 15 06:42:41
GG Gilead Sciences, Inc. Stock Forum http://t.co/ZDrIlyuhjx $GG $AA $MINE $ARIA #GG #finance #stock
30 Jul 15 06:42:40
GG Gilead Sciences, Inc. Stock Forum http://t.co/3MMmqxieUw $GG $AA $MINE $ARIA #GG #finance #stock
30 Jul 15 06:42:40
GG Gilead Sciences, Inc. Stock Forum http://t.co/Bm60CYRJ85 $GG $AA $MINE $ARIA #GG #finance #stock
30 Jul 15 06:42:39
GG Gilead Sciences, Inc. Stock Forum http://t.co/ZWXanmAVAL $GG $AA $MINE $ARIA #GG #finance #stock
30 Jul 15 06:40:36
GDXJ General Electric Co. Day Low http://t.co/h9urYtHIhv $GDXJ $VLO $GILD $ARIA #GDXJ #investing #stocks
30 Jul 15 06:40:35
FTAL.L First Trust Dorsey Wright Focus 5 ETF Open http://t.co/glcRKDgHMP $FTAL.L $ARIA $CURE $VXX #FTAL.L #nasdaq #tradeideasFV…
30 Jul 15 06:38:45
FTAL.L First Trust Dorsey Wright Focus 5 ETF Open http://t.co/mLXJof6rlq $FTAL.L $ARIA $CURE $VXX #FTAL.L #nasdaq #tradeideasFV…
By  +Follow November 12, 2013 8:57AM



blog comments powered by Disqus

 Today's Must Reads

5 Small-Cap Energy with Hedges to Survive Oil's Bear Market

DraftKings and FanDuel: The New Face of Legalized Online Sports Betting

Is the Market Paying the Toll of Tech?

What Will Uber Look Like in the Future?

How Dodd-Frank Divides Political Parties Prior to 2016 Election


Apple (AAPL) is expected to announce its latest quarterly earnings next week. As the most valuable company by mark... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register